Shanghai's SARI Pays $359M for Italian Cancer Biopharma NMS Post author:Sam Post published:December 28, 2017 Post category:BioPharma The parts expect the closing in the first quarter 2018. Source: BioSpace You Might Also Like UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D June 14, 2017 <b>Quanta</b> Appoints World Leading Nephrologist To Medical Advisory Board February 5, 2017 Cancer Biotech Apellis Pharma Sets Terms for $150M IPO October 30, 2017
UK Charity to Use $638 Million Cash From Merck & Co.'s Blockbuster Keytruda to Back R&D June 14, 2017
